05/16/2025
6:07 PM | Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
6:07 PM | Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
6:07 PM | Higa Tomohiro (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
8:32 AM | Tenaya Therapeutics (Subject)
Woodline Partners LP (Filed by)
| Form SCHEDULE 13G | |
05/14/2025
3:18 PM | COLUMN GROUP III, LP (Filed by)
Tenaya Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
05/07/2025
3:18 PM | Tenaya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2025
8:31 AM | Empery Asset Management, LP (Filed by)
Tenaya Therapeutics (Subject)
| Form SCHEDULE 13G | |
04/17/2025
3:05 PM | Tenaya Therapeutics (Filer)
| Form DEF 14A | |
04/17/2025
3:08 PM | Tenaya Therapeutics (Filer)
| Form DEFA14A | |
03/31/2025
11:15 PM | Tenaya Therapeutics (Filer)
| Form EFFECT | |
03/10/2025
8:40 PM | Ali Faraz (Reporting)
Tenaya Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for TNYA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tenaya Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/10/2025
8:41 PM | Tenaya Therapeutics (Subject)
Tingley Whittemore (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
8:42 PM | Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
8:43 PM | Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
8:44 PM | Higa Tomohiro (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
3:19 PM | Tenaya Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2025
7:22 PM | Casdin Capital, LLC (Filed by)
Tenaya Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
03/07/2025
6:50 PM | COLUMN GROUP III, LP (Filed by)
Tenaya Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
03/07/2025
6:14 PM | GOEDDEL DAVID V (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:14 PM | COLUMN GROUP III GP, LP (Reporting)
COLUMN GROUP III, LP (Reporting)
COLUMN GROUP III-A, LP (Reporting)
Column Group Opportunity III GP, LP (Reporting)
Column Group Opportunity III, LP (Reporting)
TCG Opportunity III GP, LLC (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
9:52 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Tenaya Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/04/2025
3:28 PM | Tenaya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
5:42 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tenaya Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
11:51 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Tenaya Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/07/2025
7:29 PM | Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
7:30 PM | Higa Tomohiro (Reporting)
Tenaya Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2025
3:58 PM | Tenaya Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/07/2025
3:41 PM | Tenaya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Tenaya Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/28/2025
7:00 PM | Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
4:12 PM | Tenaya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
6:58 AM | Tenaya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
6:24 AM | Tenaya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
7:48 PM | Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tenaya Therapeutics (Subject)
| Form SC 13G/A | |
11/06/2024
3:20 PM | Tenaya Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/21/2024
7:35 PM | Burroughs Amy L. (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
7:37 PM | GOEDDEL DAVID V (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
7:38 PM | Lee June (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
7:39 PM | Parschauer Karah Herdman (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
7:40 PM | Srivastava Deepak (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad) Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade.
In 2023, it surged 239%. And in 2024, it soared another 171% on the year…
But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less? Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
10/21/2024
7:41 PM | Stehman-Breen Catherine (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
7:42 PM | Tenaya Therapeutics (Issuer)
Williams R Sanders (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
7:43 PM | Tenaya Therapeutics (Issuer)
Walsh Jeffrey T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
5:26 AM | Tenaya Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/19/2024
7:30 PM | Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:23 PM | Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/16/2024
7:23 PM | Ali Faraz (Reporting)
Tenaya Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
7:24 PM | Tenaya Therapeutics (Subject)
Tingley Whittemore (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
7:25 PM | Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:26 PM | Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:24 PM | Tenaya Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/25/2024
3:02 PM | Tenaya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
4:10 PM | Tenaya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy TNYA Stock Free TNYA Stock Alerts